Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice

Travel Medicine and Infectious Disease

Volumn 6, Issue 5, 2008, Pages 253-258

  Van Nassauw, Luc ^a   Toovey, Stephen ^b,c   Van Op den bosch, Joeri ^a   Timmermans, Jean Pierre ^a   Vercruysse, Jozef ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Anti schistosomal activity; Mastocytosis; Mefloquine; Mouse; Schistosomiasis

Indexed keywords

MEFLOQUINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; EGG PRODUCTION; MALE; MAST CELL; MASTOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SINGLE DRUG DOSE; WORM EGG; WORM INFECTION;

ANIMALS; ANTIPROTOZOAL AGENTS; INTESTINES; MALE; MEFLOQUINE; MICE; PARASITE EGG COUNT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 50049093475     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2008.06.006     Document Type: Article

References (39)

1. El-Garem A.A. Schistosomiasis. Digestion 59 (1998) 589-605
2. Chitsulo L., Engels D., Montresor A., and Savioli L. The global status of schistosomiasis and its control. Acta Trop 77 (2000) 41-45
3. Gryseels B., Polman K., Clerinx J., and Kestens L. Human schistosomiasis. Lancet 368 (2006) 1106-1118
4. Vercruysse J., and Gabriel S. Immunity to schistosomiasis in animals: an update. Parasite Immunol 27 (2005) 289-295
5. 2+ channels target of praziquantel action?. Int J Parasitol 35 (2005) 1-9
6. Caffrey C.R. Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11 (2007) 433-439
7. Hennessy M., and Spiers J.P. A primer of the mechanics of P-glycoprotein in the multidrug transporter. Pharmacol Res 55 (2007) 1-15
8. Kerboeuf D., Blackhall W., Kaminsky R., and von Samson-Himmelstjerna G. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. Int J Antimicrob Agents 22 (2003) 332-346
9. Lan L.B., Ayesh S., Lyubimov E., Pashinsky I., and Stein W.D. Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing. Cancer Chemother Pharmacol 38 (1996) 181-190
10. Riffkin C.D., Chung R., Wall D.M., Zalcberg J.R., Cowman A.F., Foley M., et al. Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Biochem Pharmacol 52 (1996) 1545-1552
11. Shao Y.M., Ayesh S., and Stein W.D. Mutually co-operative interactions between modulators of P-glycoprotein. Biochim Biophys Acta 1360 (1997) 30-38
12. Pham Y.T., Regina A., Farinotti R., Couraud P., Wainer I.W., Roux F., et al. Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalized rat brain capillary endothelial cell line, GPNT. Biochim Biophys Acta 1524 (2000) 212-219
13. Barraud de Lagerie S., Comets E., Gautrand C., Fernandez C., Auchere D., Singlas E., et al. Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice. Br J Pharmacol 141 (2004) 1214-1222
14. Bosch I.B., Wang Z.-X., Tao L.-F., and Shoemaker C.B. Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins. Mol Biochem Parasitol 65 (1994) 351-356
15. Sato H., Kusel J.R., and Thornhill J. Functional visualization of the excretory system of adult Schistosoma mansoni by the fluorescent marker resorufin. Parasitology 125 (2002) 527-535
16. Sato H., Kusel J.R., and Thornhill J. Excretion of fluorescent substrates of mammalian multidrug resistance-associated protein (MRP) in the Schistosoma mansoni excretory system. Parasitology 128 (2004) 43-52
17. Weinstock J.V., and Boros D.L. Modulation of granulomatous hypersensitivity 1. T lymphocyte subsets influence mast cell density in liver granulomas of Schistosoma mansoni-infected mice. J Immunol 131 (1983) 959-961
18. Miller H.R.P., Newlands G.F.J., McKellar A., Inglis L., Coulson P.S., and Wilson R.A. Hepatic recruitment of mast cells occurs in rats but not in mice infected with Schistosoma mansoni. Parasite Immunol 16 (1994) 145-155
19. De Jonge F., Van Nassauw L., Van Meir F., Miller H.R.P., Van Marck E., and Timmermans J.-P. Temporal distribution of distinct mast cell phenotypes during intestinal schistosomiasis in mice. Parasite Immunol 24 (2002) 225-231
20. Smithers S.R., and Terry J.R. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55 (1965) 695-700
21. Morris T.H. Therapeutics. In: Flecknell P. (Ed). Manual of rabbit medicine and surgery (2000), British Small Animal Veterinary Association, Gloucester 89-101 2000
22. ter Kuile F.O., Nosten F., Thieren M., Luxemburger C., Edstein M.D., Chongsuphajaisiddhi T., et al. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis 166 (1992) 1393-1400
23. Chanthavanich P., Looareesuwan S., White N.J., Warrell D.A., Warrell M.J., DiGiovanni J.H., et al. Intragastric mefloquine is absorbed rapidly in patients with cerebral malaria. Am J Trop Med Hyg 34 (1985) 1028-1036
24. Close B., Banister K., Baumans V., Bernoth E.-M., Bromage N., Bunyan J., et al. Recommendations for euthanasia of experimental animals: Part1. Lab Anim 30 (1996) 293-316
25. Pellegrino J., Oliveira C.A., Faria J., and Cunha A.S. New approach to the screening of drugs in experimental Schistosomiasis mansoni in mice. Am J Trop Med Hyg 11 (1962) 201-215
26. Pellegrino J., and Faria J. The oogram method for the screening of drugs in Schistosomiasis mansoni. Am J Trop Med Hyg 14 (1965) 363-369
27. Scudamore C.L., McMillan L., Thornton E.M., Wright S.H., Newlands G.F.J., and Miller H.R.P. Mast cell heterogeneity in the gastrointestinal tract: variable expression of mouse mast cell protease-1 (mMCP-1) in intraepithelial mucosal mast cells in nematode-infected and normal BALB/c mice. Am J Pathol 150 (1997) 1661-1672
28. Cheever A.W., Lenzi J.A., Lenzi H.L., and Andrade Z.A. Experimental models of Schistosoma mansoni infection. Mem Inst Oswaldo Cruz 97 (2002) 917-940
29. Hoerauf A., Mand S., Adjei O., Fleischer B., and Büttner D.W. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357 (2001) 1415-1416
30. Riou M., Koch C., Delaleu B., Berthon P., and Kerboeuf D. Immunolocalisation of an ABC transporter, P-glycoprotein, in the eggshells and cuticles of free-living and parasitic stages of Haemonchus contortus. Parasitol Res 96 (2005) 142-148
31. Xiao S.H., and Catto B.A. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 33 (1989) 1557-1562
32. Xiao S.H., Yue W.J., Yang Y.Q., and You J.Q. Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. Chin Med J 100 (1987) 759-768
33. Utzinger J., Chollet J., You J.Q., Mei J.Y., Tanner M., and Xiao S.H. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop 80 (2001) 9-18
34. Xiao S.H., Tanner M., N'Goran E.K., Utzinger J., Chollet J., Bergquist R., et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 82 (2002) 175-181
35. Palmer K.J., Holliday S.M., and Brogden R.N. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45 (1993) 430-475
36. Van Nassauw L., Adriaensen D., and Timmermans J.-P. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton Neurosci 133 (2007) 91-103
37. Go M.L., and Lee H.S. Action of mefloquine on agonist-induced contractions of the guinea-pig isolated ileum. Clin Exp Pharmacol Physiol 15 (1988) 427-431
38. Mutapi F., Ndhlovu P.D., Hagan P., and Woolhouse M.E.J. Anti-schistosome antibody responses in children coinfected with malaria. Parasite Immunol 22 (2000) 207-209
39. Remoue F., Diallo T.O., Angeli V., Hervé M., de Clercq D., Schacht A.M., et al. Malaria co-infection in children influences antibody responses to schistosome antigens and inflammatory markers associated with morbidity. Trans R Soc Trop Med Hyg 97 (2003) 361-364